Compound Detail
CHEMBL3190554
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3190554 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DZVKZQACAGTRQB-UDWIEESQSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
337.4
MW (Da)
3.90
ALogP
5
HBA
1
HBD
67.5
PSA (Ų)
0.57
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.78
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Eyes absent homolog 2 CHEMBL1293275 | IC50 | 4.78 | 4.46 | 16800.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Eyes absent homolog 2 | IC50 | = | 16800.0 | nM | 4.78 | Inhibition of GST-fused human Eya2 ED (253 to 538 residues) expressed in Escheri... | - |
| Eyes absent homolog 2 | IC50 | = | 73000.0 | nM | 4.14 | Inhibition of GST-fused human Eya2 ED (253 to 538 residues) expressed in Escheri... | - |
Data from ChEMBL 36 via Core Engine